The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
This paragraph explains how to identify dividend ETFs with the lowest management fees and compare options side by side.
27,460 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
As the spring market heats up, lenders confront a truth: lower rates alone won’t shield borrowers from long-term affo...
Today’s market shows a blend of volatility and opportunity. Planet Labs led a surge on strong earnings, while broader...
What would it take for a single stock to reach a $2 trillion value in seven years? This article breaks down the drive...
Barclays and Truist each updated price targets for Carnival ahead of the March 27, 2026 Q1 release, signaling a split...
Oil's easing path and softer inflation risk push Bitcoin toward a breakout. Traders say sentiment could hinge on geop...
A tiny $1,800 token purchase has triggered a governance attack on Moonwell, risking over $1 million in funds. Analyst...
Investors are recalibrating after airports report faster screening and shorter lines, sparking a mixed revaluation of...
A major national poll released this week reveals broad dissatisfaction with the economy, a finding that may influence...
Explore Viemed's 2026 earnings outlook with a practical, numbers-driven view. Learn the key drivers, risks, and how t...
Stocks rise on May 7, 2026 as AI-driven demand powers gains in the S&P 500 and SPY. Traders weigh earnings catalysts ...
Technology firms are slashing thousands of roles as AI adoption accelerates. Coinbase, Cloudflare, and Upwork lead a ...